These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 29102598)

  • 21. Hematopoiesis-related microRNA expression in myelodysplastic syndromes.
    Pons A; Nomdedeu B; Navarro A; Gaya A; Gel B; Diaz T; Valera S; Rozman M; Belkaid M; Montserrat E; Monzo M
    Leuk Lymphoma; 2009 Nov; 50(11):1854-9. PubMed ID: 19883312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes.
    Kuang X; Wei C; Zhang T; Yang Z; Chi J; Wang L
    Int J Oncol; 2016 Nov; 49(5):1921-1930. PubMed ID: 27633496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Dostalova Merkerova M; Krejcik Z; Votavova H; Belickova M; Vasikova A; Cermak J
    Eur J Hum Genet; 2011 Mar; 19(3):313-9. PubMed ID: 21150891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
    Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
    J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients.
    von der Heide EK; Neumann M; Vosberg S; James AR; Schroeder MP; Ortiz-Tanchez J; Isaakidis K; Schlee C; Luther M; Jöhrens K; Anagnostopoulos I; Mochmann LH; Nowak D; Hofmann WK; Greif PA; Baldus CD
    Leukemia; 2017 May; 31(5):1069-1078. PubMed ID: 27833093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia.
    Guo Y; Strickland SA; Mohan S; Li S; Bosompem A; Vickers KC; Zhao S; Sheng Q; Kim AS
    Leuk Lymphoma; 2017 Sep; 58(9):1-15. PubMed ID: 28084850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An miRNA-DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia.
    Solly F; Koering C; Mohamed AM; Maucort-Boulch D; Robert G; Auberger P; Flandrin-Gresta P; Adès L; Fenaux P; Kosmider O; Tavernier-Tardy E; Cornillon J; Guyotat D; Campos L; Mortreux F; Wattel E
    Clin Cancer Res; 2017 Jun; 23(12):3025-3034. PubMed ID: 27881579
    [No Abstract]   [Full Text] [Related]  

  • 30. Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes.
    Wan C; Wen J; Huang Y; Li H; Wu W; Xie Q; Liang X; Tang Z; Zhao W; Cheng P; Liu Z
    Medicine (Baltimore); 2020 Jul; 99(27):e20904. PubMed ID: 32629683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation.
    Borze I; Scheinin I; Siitonen S; Elonen E; Juvonen E; Knuutila S
    Leuk Lymphoma; 2011 Aug; 52(8):1567-73. PubMed ID: 21649547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes.
    Choi JS; Nam MH; Yoon SY; Kang SH
    Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes.
    Xu F; Zhu Y; He Q; Wu LY; Zhang Z; Shi WH; Liu L; Chang CK; Li X
    Sci Rep; 2016 Aug; 6():32232. PubMed ID: 27571714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
    Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J
    Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of microRNAs in basal cell carcinoma.
    Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA Expression Profiling in Adrenal Myelolipoma.
    Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.
    Lopes MR; Pereira JK; de Melo Campos P; Machado-Neto JA; Traina F; Saad ST; Favaro P
    Sci Rep; 2017 Jan; 7():40707. PubMed ID: 28084439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.